Repository logo
 
Publication

Late Gadolinium Enhancement in the Left Ventricular Wall Is Associated with Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy

dc.contributor.authorCastelo, A
dc.contributor.authorAguiar Rosa, S
dc.contributor.authorFiarresga, A
dc.contributor.authorJalles, N
dc.contributor.authorVaz Ferreira, V
dc.contributor.authorGarcia Brás, P
dc.contributor.authorBranco, L
dc.contributor.authorOliveira, M
dc.contributor.authorCruz Ferreira, R
dc.date.accessioned2024-03-14T16:30:40Z
dc.date.available2024-03-14T16:30:40Z
dc.date.issued2022-12
dc.description.abstractPurpose: Atrial fibrillation (AF) is the most common arrhythmia in patients with hypertrophic cardiomyopathy (HCM). The aim of this study was to evaluate the relation between AF and left ventricular (LV) late gadolinium enhancement (LGE). Methods: 55 patients with HCM were retrospectively included. Patients were divided in HCM with AF and HCM without AF. Baseline clinical, echocardiographic and cardiovascular magnetic resonance (CMR) characteristics were collected and compared between groups. Results: In univariable analysis, the factors related to AF development were HCM risk score for sudden cardiac death (SCD) > 2.29% (p = 0.002), left atrium (LA) diameter > 42.5 mm (p = 0.014) and LGE in the mid anterior interventricular septum (IVS) (p = 0.021), basal inferior IVS (p = 0.012) and mid inferior IVS (p = 0.012). There were no differences in LV diastolic function and LA strain between groups. Independent predictors of AF were LA diameter (p = 0.022, HR 5.933) and LGE in mid inferior IVS (p = 0.45, HR 3.280). Combining LA diameter (> 42.5 mm or < 42.5 mm) and LGE in mid inferior IVS (present or absent) in a model with four groups showed a statistically significant difference between groups (p = 0.013 for the model). Conclusions: LGE in mid inferior IVS is an independent predictor for AF occurrence in patients with HCM. Combining both LGE in mid inferior IVS and enlarged LA improves prediction of AF and may be preferred for risk stratification.pt_PT
dc.description.versioninfo:eu-repo/semantics/publishedVersionpt_PT
dc.identifier.citationInt J Cardiovasc Imaging . 2022 Dec;38(12):2733-2741pt_PT
dc.identifier.doi10.1007/s10554-022-02642-8pt_PT
dc.identifier.urihttp://hdl.handle.net/10400.17/4839
dc.language.isoengpt_PT
dc.peerreviewedyespt_PT
dc.publisherSpringerpt_PT
dc.subjectHSM CARpt_PT
dc.subjectHumanspt_PT
dc.subjectAtrial Fibrillation* / complicationspt_PT
dc.subjectAtrial Fibrillation* / diagnostic imagingpt_PT
dc.subjectCardiomyopathy, Hypertrophic* / complicationspt_PT
dc.subjectCardiomyopathy, Hypertrophic* / diagnostic imagingpt_PT
dc.subjectContrast Mediapt_PT
dc.subjectGadoliniumpt_PT
dc.subjectPredictive Value of Testspt_PT
dc.subjectRetrospective Studiespt_PT
dc.titleLate Gadolinium Enhancement in the Left Ventricular Wall Is Associated with Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathypt_PT
dc.typejournal article
dspace.entity.typePublication
oaire.citation.endPage2741pt_PT
oaire.citation.issue12pt_PT
oaire.citation.startPage2733pt_PT
oaire.citation.titleThe International Journal of Cardiovascular Imagingpt_PT
oaire.citation.volume38pt_PT
rcaap.rightsopenAccesspt_PT
rcaap.typearticlept_PT

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
IJCI 2022 2733.pdf
Size:
1.09 MB
Format:
Adobe Portable Document Format
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:

Collections